Minomic
Business Services · Australia · 11-50 Employees
View Company Info for Free
Overview
Headquarters
3 Innovation Rd L 1, Macquarie Park, New...Website
www.minomic.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Minomic
Minomic is an Australian company focused on the commercialization of innovative tests for solid tumors, particularly in prostate, bladder, and pancreatic cancers. They have developed a prostate cancer blood test called MiCheck® Prostate, which is currently available in the US and Australia. The test utilizes a patented monoclonal antibody and other biomarkers to provide a clinically significant risk score for prostate cancer, assisting urologists in biopsy decisions. Minomic aims to improve patient outcomes through their comprehensive intellectual property portfolio and strategic partnerships.Explore more
Minomic Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Minomic your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Minomic
Click to see if Minomic had a recent Job posting/layoffs
Check if Minomic has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Minomic, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Minomic recently announced quarterly report
Product Launch: Get notified when Minomic launches new products
Funding: Get notified immidiatlly once Minomic has new funding data
Check out if Minomic is spiking on competitors!
Website visits: Recent activity has been detected on your website
Recommended Actions
Reach out to Masked Content who joined Minomic as Masked Content
Find 3 more new buyers
Compare Similar Companies to Minomic
Compare insights from companies similar to Minomic, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Minomic is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Minomic is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Minomic.
Minomic financials insights
Gather financial insights about Minomic, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2016
Private Equity
$3.7M
Minomic Tech Stack
A closer look at the technologies used by Minomic
Minomic News & Media
Minomic Signs Agreement with US Pathology Laboratory
SYDNEY--(BUSINESS WIRE)--#minomic--Minomic has executed an agreement with Cirrus Dx, enabling US clinicians and patients’ early access to the company’s novel test for Prostate Cancer.Minomic Announces Completion of Demerger of GlyTherix Ltd
SYDNEY--(BUSINESS WIRE)--#DrBradWalsh--The demerger of Minomic's therapeutic subsidiary GlyTherix to clear the path for company capital raisingMinomic Secures Key Patent in the United States and China
SYDNEY--(BUSINESS WIRE)--#glypican1--Minomic has announced the grant of its patent 'Cell surface prostate cancer antigen for diagnosis' in the key global markets of the US and China.Minomic Announces Completion of Accrual for Clinical Study of Miltuximab® in Prostate, Bladder and Pancreatic Cancers
SYDNEY--(BUSINESS WIRE)--#ClinicalStudy--Miltuximab is well tolerated with patients reporting no drug related adverse events. These results will inform the future development of the drug.
Read more news
Top Business Services Companies
Frequently Asked Questions Regarding Minomic
Sign Up For FreeTo access detailed company insights
Minomic is an Australian company focused on the commercialization of innovative tests for solid tumors, particularly in prostate, bladder, and pancreatic cancers. They have developed a prostate cancer blood test called MiCheck® Prostate, which is currently available in the US and Australia. The test utilizes a patented monoclonal antibody and other... Read More
